Ophthalmology

SDC Optimizes Focus on Tech-Enabled Biometric Services

Retrieved on: 
Tuesday, March 5, 2024
Technology, Research, Other Technology, Health Technology, Biotechnology, Health, Pharmaceutical, Optical, Science, Ophthalmology, Ora, SDC, Biostatistics, IRT, Clinical trial, Statistics, Data management, EDC, Partnership

Statistics & Data Corporation (SDC), a global leader in life sciences biometrics services and technology solutions, announces a strategic decision to enhance focus and efficiency by transitioning its ophthalmic biometric division to its partner Ora, Inc.

Key Points: 
  • Statistics & Data Corporation (SDC), a global leader in life sciences biometrics services and technology solutions, announces a strategic decision to enhance focus and efficiency by transitioning its ophthalmic biometric division to its partner Ora, Inc.
  • During this time, SDC has developed a reputation as an industry leader in providing biometrics services and the deployment of innovative/integrated technologies across the industry.
  • Dr. Richard Abelson, CEO of SDC commented, "The transition of our ophthalmic biometric division signifies our unwavering dedication to excellence and innovation in clinical research services and technology solutions.
  • This strategic shift allows SDC to better leverage our core strengths and deliver greater value to our clients and clinical partnerships."

Stephen Carrier joins Health Network One as Network President

Retrieved on: 
Friday, March 1, 2024
Practice Management, Physical Therapy, Optical, Managed Care, General Health, Health, Health Insurance, Other Health, Ophthalmology, Senior, Dispatch, Growth, Dermatology, MBA, Cigna, University, United, Carrier, Podiatry, Management

Health Network One, a leader in value-based healthcare solutions, recently welcomed Stephen (Steve) Carrier as Network President.

Key Points: 
  • Health Network One, a leader in value-based healthcare solutions, recently welcomed Stephen (Steve) Carrier as Network President.
  • Health Network One creates value for managed care organizations by taking on the unique complexities of specialty networks.
  • Luis Mosquera, CEO of Health Network One, expressed his enthusiasm about the new appointment, “We are thrilled to welcome Steve to our team as Network President.
  • Steve brings a wealth of experience in managed care and a proven track record of innovative leadership in value-based healthcare solutions.”
    Carrier is a seasoned managed care strategist, who joins Health Network One from Dispatch Health.

Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)

Retrieved on: 
Thursday, February 29, 2024
Chemicals, Plastics, Health, Manufacturing, Pharmaceutical, Optical, Biotechnology, Therapy, Ophthalmology, CE, FDA, Travoprost, Food, Eye, Lung compliance, Safety, RNA, Ocular hypertension, Patient, Corporation, Glaucoma

Sustained delivery of therapeutics provides an important approach in addressing non-compliance and improving treatment outcomes.

Key Points: 
  • Sustained delivery of therapeutics provides an important approach in addressing non-compliance and improving treatment outcomes.
  • With iDose® TR and the VitalDose® EVA, there is now the opportunity to provide continuous dosing which can improve patient compliance and address adherence issues.
  • iDose® TR was approved on the basis of two pivotal trials (1,150 subjects randomized across both trials), which demonstrated safety and efficacy.
  • Glaukos used the VitalDose® EVA to create a nanoporous membrane for travoprost delivery in iDose® TR.

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair

Retrieved on: 
Monday, February 26, 2024
Medical Supplies, Medical Devices, Health, Pharmaceutical, Optical, Biotechnology, Ophthalmology, FDA, Optometry, Physician, MBA, Pharma, Drainage, Pulse, Eye surgery, Telecanthus, Patient, MAB, Congress, Chair, Pharmaceutical industry

Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory Board (MAB) which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma).

Key Points: 
  • Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory Board (MAB) which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma).
  • Dr. Donnenfeld joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® canalicular gel.
  • The FDA-cleared hyaluronic acid derivative LACRIFILL is intended to temporarily block tear drainage by the occlusion of the canalicular system.
  • “Nordic Pharma continues to build a world class group of key opinion leaders with Eric agreeing to lead our esteemed MAB in the U.S. as we prepare to bring LACRIFILL to market.

New Swiss Made Features for Cataract Surgery Lens Selection

Retrieved on: 
Thursday, February 22, 2024
Technology, Medical Devices, Surgery, Health Technology, Software, Other Health, Biometrics, Biotechnology, Health, Optical, Astigmatism, PCA, Biostatistics, Multimedia, Lens, Retina, Cataract, Intraocular lens, Vision, Image, Ophthalmology, Patient, Headache, Telescopic sight

The company Swiss Advanced Vision (SAV-IOL SA) has announced the launch of New Features for its Toric Calculator improving the overall calculation experience.

Key Points: 
  • The company Swiss Advanced Vision (SAV-IOL SA) has announced the launch of New Features for its Toric Calculator improving the overall calculation experience.
  • View the full release here: https://www.businesswire.com/news/home/20240222791326/en/
    Launch of New Features, discover the unique Incision Location Optimization tool on SAV-IOL Toric Calculator.
  • Since 2009, the Swiss company has been developing advanced IOLs with the goal to restore the missing accommodation left by the removal of the natural lens.
  • Swiss Advanced Vision will keep the pace of innovative product development and is already working on new functionalities for their users, stay tuned!

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance

Retrieved on: 
Wednesday, February 21, 2024
Medical Supplies, Medical Devices, Health, Surgery, Pharmaceutical, Optical, Acquisition, Ophthalmology, Bausch, Care, Forecasting, News, Bausch & Lomb, Intraocular lens, Adjustment, GAAP, EPS, Ultra, Video game

For the fourth quarter of 2023, the change was primarily due to higher interest expense and the decrease in operating results noted above.

Key Points: 
  • For the fourth quarter of 2023, the change was primarily due to higher interest expense and the decrease in operating results noted above.
  • Adjusted EPS attributable to Bausch + Lomb Corporation (non-GAAP)1 for the fourth quarter of 2023 was $0.24, as compared to $0.23 for the fourth quarter of 2022.
  • Adjusted EPS attributable to Bausch + Lomb Corporation (non-GAAP)1 for the full year of 2023 was $0.73, as compared to $1.07 for the full year of 2022.
  • Bausch + Lomb provided guidance for the full year of 2024, as follows.

Apollo Intelligence, a Frazier Healthcare Portfolio Company, Acquires GlocalMind, Expanding its Global Reach and Operations in Healthcare and Life Science Market Insights

Retrieved on: 
Tuesday, February 20, 2024
Other Communications, Marketing, Advertising, Communications, Other Technology, Mobile, Wireless, Software, Other Science, Data Analytics, Research, Pharmaceutical, Internet, Data Management, Hospitals, Technology, Other Professional Services, Science, Practice Management, Veterinary, Nursing, Managed Care, Health, General Health, Consulting, Health Technology, Professional Services, Acquisition, Alvarez and Marsal, Dentist, Goodwin Procter, Culture, Intelligence, Veterinarian, Pharmacist, Ophthalmology, LLP

Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries, has acquired GlocalMind , a global technology-driven healthcare market research services and panel company.

Key Points: 
  • Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries, has acquired GlocalMind , a global technology-driven healthcare market research services and panel company.
  • The acquisition of GlocalMind marks Apollo’s third move since 2019 to enhance its life science market insights offering, setting it apart in the industry.
  • With a steadfast dedication to advancing healthcare and life sciences market research through technology and data, Apollo reaffirms its commitment to accelerating health innovation for a better life.
  • “Life science companies face unprecedented demands to bring new therapies to market faster than ever before.

Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034

Retrieved on: 
Thursday, March 7, 2024
Ophthalmology, Corning, Eye, Infection, Research, Medicine, OTC, Indian stock exchange, Ageing, Growth, Projection, Allergy, Prevalence, Safety, Glass, Macular degeneration, Gel, Health, Patient, FMI, Knowledge, Sample, Glaucoma

Ophthalmic Drug Packaging Market Overview:

Key Points: 
  • Ophthalmic Drug Packaging Market Overview:
    The global ophthalmic drug packaging market is expected to grow steadily, reaching an estimated value of US$527.8 million by 2034, according to Future Market Insights' recent study.
  • One of the challenges in the global ophthalmic drug packaging market is assuring compatibility between novel packaging materials and sensitive ophthalmic medicines.
  • The global ophthalmic drug packaging market size reached US$ 222.3 million in 2019.
  • Future Market Insights offers an unbiased analysis of the ophthalmic drug packaging market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034

Retrieved on: 
Thursday, March 7, 2024
Ophthalmology, Corning, Eye, Infection, Research, Medicine, OTC, Indian stock exchange, Ageing, Growth, Projection, Allergy, Prevalence, Safety, Glass, Macular degeneration, Gel, Health, Patient, FMI, Knowledge, Sample, Glaucoma

Ophthalmic Drug Packaging Market Overview:

Key Points: 
  • Ophthalmic Drug Packaging Market Overview:
    The global ophthalmic drug packaging market is expected to grow steadily, reaching an estimated value of US$527.8 million by 2034, according to Future Market Insights' recent study.
  • One of the challenges in the global ophthalmic drug packaging market is assuring compatibility between novel packaging materials and sensitive ophthalmic medicines.
  • The global ophthalmic drug packaging market size reached US$ 222.3 million in 2019.
  • Future Market Insights offers an unbiased analysis of the ophthalmic drug packaging market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

Dr. Kent Wellish Successfully Implants First Bausch + Lomb Toric Aspire "Range of Vision" IOL in Las Vegas

Retrieved on: 
Thursday, March 7, 2024
Cataract, Ophthalmology, Astigmatism, Screen time, Patient, IOL, Bausch, Telescopic sight

PHOENIX, March 7, 2024 /PRNewswire-PRWeb/ -- Dr. Kent Wellish of Wellish Vision Institute, an affiliate of American Vision Partners, has achieved a significant milestone in the field of ophthalmology by successfully implanting the first Bausch + Lomb Toric Aspire "Range of Vision" intraocular lens (IOL) in Las Vegas. This innovative lens offers patients with cataracts the potential for improved vision at various distances.

Key Points: 
  • Dr. Kent Wellish of Wellish Vision Institute, an affiliate of American Vision Partners, has achieved a significant milestone in the field of ophthalmology by successfully implanting the first Bausch + Lomb Toric Aspire "Range of Vision" intraocular lens (IOL) in Las Vegas.
  • PHOENIX, March 7, 2024 /PRNewswire-PRWeb/ -- Dr. Kent Wellish of Wellish Vision Institute, an affiliate of American Vision Partners, has achieved a significant milestone in the field of ophthalmology by successfully implanting the first Bausch + Lomb Toric Aspire "Range of Vision" intraocular lens (IOL) in Las Vegas.
  • The Bausch + Lomb Toric Aspire "Range of Vision" IOL, recently launched as Envista Aspire is designed to provide an extended range of vision, including intermediate vision, reducing the need for glasses for activities such as reading, computer use, and driving.
  • Visit https://ir.bausch.com/ for more information about the Bausch + Lomb Toric Aspire "Range of Vision" IOL.